Gainers
ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.3% to $1.03 during Wednesday's after-market session. The company's market cap stands at $33.2 million.
-- Presentation at ASCO features updated results from Phase 2 ACCURACY study --
-- AL101 demonstrated anti-tumor activity by achieving an overall disease control rate of 69% --
-- Patients achieving partial
Ayala Pharmaceuticals (NASDAQ:AYLA) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers, today